-
Private sector expresses willingness to partner with government for COVID-19 vaccine administration
expresspharma
January 08, 2021
FICCI has submitted a detailed plan outlining what support private sector, including healthcare, can provide, through the FICCI-EY Strategy paper on ‘Protecting India – Public-Private Partnership for vaccinating against COVID-19’, submitted to NEGVAC ...
-
Cellid signs Covid-19 vaccine research contract with IVI
pharmaceutical-technology
January 07, 2021
Cellid and the International Vaccine Institute (IVI) have signed a research service contract to collaborate in the clinical development of the Covid-19 vaccine, AdCLD-CoV19.
-
Colombia grants emergency use approval for Pfizer-BioNTech Covid-19 vaccine
pharmaceutical-technology
January 07, 2021
Colombia’s National Institute of Drug and Food Surveillance (INVIMA) has authorised emergency use of Pfizer and BioNTech’s Covid-19 vaccine.
-
GMR Hyderabad and Dubai Airports sign MoU for worldwide distribution of COVID-19 Vaccine
expresspharma
January 07, 2021
MoU to position Hyderabad-Dubai Air Freight Corridor as Global Gateway for safe and efficient movement of COVID-19 Vaccine shipments Worldwide.
-
Australia brings forward COVID-19 vaccine roll-out to early March
expresspharma
January 07, 2021
The government plans to complete a mass inoculation programme for its 25 million citizens by the end of this year.
-
AstraZeneca applies for emergency use for vaccine in Philippines
expresspharma
January 07, 2021
AstraZeneca has applied to health regulators for emergency use authorisation (EUA) of its COVID-19 vaccine in the Philppines, the food and drugs agency chief said on Wednesday.
-
Ukrainian firm applies to make Russia’s COVID-19 vaccine, sparking political dilemma
expresspharma
January 07, 2021
Zelenskiy’s government is looking to secure COVID-19 vaccines from China and the global COVAX scheme for poorer nations to fight the pandemic.
-
Germany says does not intend to delay second COVID-19 vaccine shot
expresspharma
January 07, 2021
Germany intends to stick to recommendations by BioNTech and Pfizer regarding the administration of a second dose of their COVID-19 vaccines rather than delaying it, Health Minister Jens Spahn said on Wednesday.
-
China grants conditional market approval for Sinopharm CNBG's COVID-19 vaccine
worldpharmanews
January 06, 2021
The inactivated COVID-19 vaccine developed by Beijing Institute of Biological Products of Sinopharm CNBG has been granted conditional registration by the NMPA of China, Chinese equivalent of FDA, according to a press conference of the ...
-
Apex Innovative Sciences Supports Three Major COVID-19 Vaccine Trials
prnewswire
January 06, 2021
Apex Innovative Sciences (Apex) and its affiliates are proud to announce their participation in three COVID-19 vaccine studies.